{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:16:05Z","timestamp":1787019365003,"version":"build-2736575974"},"reference-count":94,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Hematology"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Bruton\u2019s tyrosine kinase (BTK) inhibitors have dramatically changed the treatment of newly diagnosed and relapsed\/refractory chronic lymphocytic leukemia (CLL). Ibrutinib, acalabrutinib, and zanubrutinib are Food and Drug Administration (FDA)-approved BTK inhibitors that have all demonstrated progression-free survival (PFS) benefit compared with chemoimmunotherapy. The efficacy of these agents compared to one another is under study; however, current data suggest they provide similar efficacy. Selectivity for BTK confers different adverse effect profiles, and longer follow-up and real-world use have characterized side effects over time. The choice of BTK inhibitor is largely patient-specific, and this review aims to highlight the differences among the agents and guide the choice of BTK inhibitor in clinical practice.<\/jats:p>","DOI":"10.1177\/20406207221116577","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T08:59:36Z","timestamp":1660035576000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":13,"title":["Selecting the optimal BTK inhibitor therapy in CLL: rationale and practical considerations"],"prefix":"10.1177","volume":"13","author":[{"given":"Alexandra R.","family":"Lovell","sequence":"first","affiliation":[{"name":"Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadya","family":"Jammal","sequence":"additional","affiliation":[{"name":"Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4343-5712","authenticated-orcid":false,"given":"Prithviraj","family":"Bose","sequence":"additional","affiliation":[{"name":"Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"bibr1-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2013.850030"},{"key":"bibr2-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1038\/361226a0"},{"key":"bibr3-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00741.x"},{"key":"bibr4-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2007.00534.x"},{"key":"bibr5-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.343"},{"key":"bibr6-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1039\/D0MD00154F"},{"key":"bibr7-20406207221116577","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11080764"},{"key":"bibr8-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.07.081"},{"key":"bibr9-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.2282"},{"key":"bibr10-20406207221116577","unstructured":"Imbruvica (ibrutinib) [package insert]. Sunnyvale, CA: Pharmacyclics, Inc. 2020."},{"key":"bibr11-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215637"},{"key":"bibr12-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400376"},{"key":"bibr13-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1908213"},{"key":"bibr14-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-870238"},{"key":"bibr15-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509388"},{"key":"bibr16-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0602-x"},{"key":"bibr17-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.7523"},{"key":"bibr18-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313984"},{"key":"bibr19-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30788-5"},{"key":"bibr20-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812836"},{"key":"bibr21-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2856"},{"key":"bibr22-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-10-810044"},{"key":"bibr23-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817073"},{"key":"bibr24-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-667675"},{"key":"bibr25-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-538116"},{"key":"bibr26-20406207221116577","unstructured":"Calquence (acalabrutinib) [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP, 2019."},{"key":"bibr27-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03355"},{"key":"bibr28-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-146570"},{"key":"bibr29-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30262-2"},{"key":"bibr30-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.15_suppl.7509"},{"key":"bibr31-20406207221116577","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.272500"},{"key":"bibr32-20406207221116577","unstructured":"Brukinsa (zanubrutinib) [package insert]. San Mateo, CA: BeiGene USA, Inc. 2021."},{"key":"bibr33-20406207221116577","unstructured":"National Comprehensive Cancer Network. Chronic lymphocytic leukemia\/small lymphocytic leukemia (version 2.2022), https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cll.pdf (2022, accessed 4 February 2022)."},{"key":"bibr34-20406207221116577","unstructured":"Hillmen P, Eichhorst B, Brown JR, et al. First interim analysis of ALPINE study: results of a phase 3 randomized study of zanubrutinib vs ibrutinib in patients with relapsed\/refractory chronic lymphocytic leukemia\/small lymphocytic lymphoma. In: 2021 European Hematology Association Virtual Congress, 11 June 2021, pp. 9\u201317, https:\/\/www.beigenemedical.com\/CongressDocuments\/Hillmen%20BGB-3111%20305%20EHA%20Abstract%202021.pdf"},{"key":"bibr35-20406207221116577","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.259432"},{"key":"bibr36-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148457"},{"key":"bibr37-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400029"},{"key":"bibr38-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00224-5"},{"key":"bibr39-20406207221116577","unstructured":"Investors L. Loxo Oncology at Lilly announces updated data from the phase 1\/2 BRUIN clinical trial for pirtobrutinib at the American Society of Hematology Annual Meeting, https:\/\/investor.lilly.com\/news-releases\/news-release-details\/loxo-oncology-lilly-announces-updated-data-phase-12-bruin-1 (2021, accessed 8 February 2022)."},{"key":"bibr40-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114110"},{"key":"bibr41-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00465-9"},{"key":"bibr42-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1795159"},{"key":"bibr43-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-879429"},{"key":"bibr44-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-651125"},{"key":"bibr45-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-05-647925"},{"key":"bibr46-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01280-8"},{"key":"bibr47-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900574"},{"key":"bibr48-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.1649"},{"key":"bibr49-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00807"},{"key":"bibr50-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-144336"},{"key":"bibr51-20406207221116577","volume-title":"26th Congress of the European Hematology Association. EHA2021 Virtual Congress","author":"Kater A"},{"key":"bibr52-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00491"},{"key":"bibr53-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00455-1"},{"key":"bibr54-20406207221116577","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(21)00307-0","volume":"8","author":"Soumerai JD","year":"2021","journal-title":"Lancet Haematol"},{"key":"bibr55-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000412"},{"key":"bibr56-20406207221116577","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.720704"},{"key":"bibr57-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000309"},{"key":"bibr58-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-823393"},{"key":"bibr59-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-818286"},{"key":"bibr60-20406207221116577","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.164285"},{"key":"bibr61-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.2437"},{"key":"bibr62-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008758"},{"key":"bibr63-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009966"},{"key":"bibr64-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01500-1"},{"key":"bibr65-20406207221116577","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3324\/haematol.2021.279457","volume":"107","author":"Besson C.","year":"2022","journal-title":"Haematologica"},{"key":"bibr66-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016001883"},{"key":"bibr67-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.07.287"},{"key":"bibr68-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02905.x"},{"key":"bibr69-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13651"},{"key":"bibr70-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.247"},{"key":"bibr71-20406207221116577","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.126672"},{"key":"bibr72-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.85.8.672"},{"key":"bibr73-20406207221116577","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.171041"},{"key":"bibr74-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-712828"},{"key":"bibr75-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-742437"},{"key":"bibr76-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2018.04.009"},{"key":"bibr77-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-12-0993-T"},{"key":"bibr78-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1057385"},{"key":"bibr79-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.16326"},{"key":"bibr80-20406207221116577","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.182907"},{"key":"bibr81-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01210"},{"key":"bibr82-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-146610"},{"key":"bibr83-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713976"},{"key":"bibr84-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1815281"},{"key":"bibr85-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-141716"},{"key":"bibr86-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17984"},{"key":"bibr87-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26437"},{"key":"bibr88-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012315"},{"key":"bibr89-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1002\/hon.49_2880"},{"key":"bibr90-20406207221116577","volume-title":"23rd Congress of the European Hematology Association","author":"Goede V"},{"key":"bibr91-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01485-x"},{"key":"bibr92-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-127260"},{"key":"bibr93-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-126286"},{"key":"bibr94-20406207221116577","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-124473"}],"container-title":["Therapeutic Advances in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20406207221116577","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20406207221116577","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20406207221116577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:16:17Z","timestamp":1777590977000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20406207221116577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":94,"alternative-id":["10.1177\/20406207221116577"],"URL":"https:\/\/doi.org\/10.1177\/20406207221116577","relation":{},"ISSN":["2040-6207","2040-6215"],"issn-type":[{"value":"2040-6207","type":"print"},{"value":"2040-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"article-number":"20406207221116577"}}